HZHaiyan Zuo

Haiyan Zuo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haiyan Zuo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Shengbing Wu

    Anhui Province Key Laboratory of Meridian Viscera Correlationship, Anhui University of Chinese Medicine, Hefei, China

    2 shared publications
  • Jie Zhou

    The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou, Zhejiang, China

    1 shared publication
  • Kun Wang

    College of Traditional Chinese Medicine

    1 shared publication
  • Lei Wang

    Changfeng Hospital of Traditional Chinese Medicine, Hefei, China

    1 shared publication
  • Meiqi Zhou

    Anhui Province Key Laboratory of Meridian Viscera Correlation ship, Anhui University of Chinese Medicine, China

    1 shared publication
  • Meiqi Zhou

    Key Laboratory of Xin’an Medicine, the Ministry of Education and Key Laboratory of Molecular Biology (Brain diseases), Anhui University of Chinese Medicine, Hefei, China

    1 shared publication

Latest Publications

  • Open Access

    Electroacupuncture alleviates acute myocardial ischemic injury in mice by regulating the β 1 adrenergic receptor and post-receptor protein kinase A signaling pathway

    by Haiyan Zuo, Qiaoyu Qu, Yan Tong, Lei Wang, Xiaoxiao Wang, Shengbing Wu, Meiqi Zhou

    Objective: To determine the effect of electroacupuncture (EA) on β 1 -adrenergic receptor (β 1 -AR) and post-receptor protein kinase A (PKA) signaling pathway after acute myocardial ischemia (MI). Methods: An MI model was established by ligating the left anterior descending coronary artery of wild-type (WT) C57/BL and β 1 -AR +/– mice (heterozygous for β 1 -AR gene deletion). EA treatment was administered at HT5-HT7 or LU9-LU8. We evaluated cardiac function by measuring ST segment displacement, ischemic area and serum levels of creatine kinase (CK)-MB and lactate dehydrogenase (LDH). Pathological morphology/apoptosis of myocardial tissue were examined using hematoxylin–eosin and terminal deoxynucleotidyl transferase dUTP nick end labeling staining. Norepinephrine (NE) levels in myocardial tissue were detected by ELISA. Levels of β 1 and post-receptor PKA signaling components were evaluated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting. Results: EA stimulation at HT7-HT5 could better regulate the level of β 1 -AR in myocardial tissue than that at LU9-LU8. Following EA, the ST segment, serum CK-MB/ LDH and area of myocardial infarction were decreased in WT mice, and the degree of myocardial pathology/apoptosis and expression of cleaved caspase-3 were decreased. Myocardial levels of Gs protein (Gs), adenylate cyclase (AC), cyclic adenosine monophosphate (cAMP), phosphorylated protein kinase A (p-PKA), L-type voltage-gated calcium channel α1C (Cav1.2), serine phosphate 16-phospholamban (p-PLB s16 ) and sarcoplasmic reticulum Ca 2+ -adenosine triphosphate (ATP)ase 2a (SERCA2a) increased after EA. However, these effects of EA were not replicated in β 1 -AR +/– mice. Interestingly, myocardial NE content decreased after EA in WT and β 1 -AR +/– mice. Conclusion: EA may enhance cardiac function and reduced MI area/apoptosis by restoring the activity of β 1 -AR and post-receptor PKA signaling.


  • Open Access

    Electroacupuncture Ameliorates Acute Myocardial Ischemic Injury and Long QT Interval in Mice through the α1A‐Adrenergic Receptor: Electrophysiological, Morphological, and Molecular Evidence

    by Haiyan Zuo, Shuai Cui, Kun Wang, Xin Wu, Jie Zhou, Qiaoyu Qu, Yan Tong, Shengbing Wu, Meiqi Zhou

    Acute myocardial ischemia (AMI) is a condition caused by a decrease in blood flow to the heart that can sometimes predispose to acquired long QT syndrome (LQTS), thereby resulting in sudden cardiac death. Recent evidence indicates that electroacupuncture (EA) can alleviate MI injury, but its specific mechanism remains unclear. This study was aimed at investigating the efficacy of EA, which utilizes α1A‐adrenergic receptors (α1A‐AR) in alleviating MI injury as well as the resulting LQTS. The AMI model was established by ligating the left anterior descending arteries (LAD) of both the wild‐type and α1A gene‐knockout mice and treating them with EA for three consecutive days. A PowerLab 16 physiological recorder was used to collect the electrocardiogram (ECG) while the serum creatine kinase isoenzymes (CK‐MB), lactate dehydrogenase (LDH), and norepinephrine (NE) levels in myocardial tissue were determined by using the enzyme‐linked immunosorbent assay (ELISA) kit. Moreover, TTC staining was used to observe the myocardial ischemic area, while H&E and TUNEL staining determined the pathological morphology of the myocardium. Quantitative real‐time PCR (qRT‐PCR) was used to detect the α1A mRNA, and Western blot was used to detect the specific proteins, such as α1A, cleaved caspase‐3, Gq, PLC, p‐PKCα, and p‐hERG. Our results showed that EA could effectively reduce elevated ST‐segment, shorten the extended QT interval, and reduce the serum myocardial enzyme content and the degree of pathological injury in wild mice with MI. EA can also decrease the expression of α1A‐AR, PLC, p‐PKCα, and NE content in myocardial tissues of wild mice, while those of p‐hERG increased in ischemic myocardial tissue. These findings suggested that α1A‐AR is involved in the development of MI as well as LQTS. Additionally, EA treatment improves the cardiac function and ischemic long QT interval and plays an important role in reducing the hERG inhibition through the α1A‐AR‐mediated Gq/PLC/PKCα pathway and myocardial apoptosis. Hence, it is suggested that α1A‐AR might become a potential target for EA in treating AMI treatment of myocardial ischemia injury and acquired long QT intervals caused by MI.